University of Pittsburgh Health Sciences eLearning Environment Internet-based Studies in Education and Research
Step by Step
INTRODUCTION
ABIM MOC Activity ID
3/13/2018 - Medical Grand Rounds: Rheumatoid Arthritis, from the clinic back to the bench & Immune Relevance of Prevotella copri, a Gut Microbe, in Patient with Rheumatoid Arthritis
QUIZ
EVALUATION
CERTIFICATE
INTRODUCTION
Credit Hours: CME 1.00
Target Audience:
Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.
Educational Objectives:
Presentation Topics
Upon completion of this activity, participants should be able to:
- Provide overview of major advances in treatment of rheumatoid arthritis.
- Review the strategies for prevention and early treatment for rheumatoid arthritis
- Describe the factors associated with poor prognosis, and challenges of treating rheumatoid arthritis
Presentation Topics
Title: Rheumatoid Arthritis, from the clinic back to the bench
Presenter: Larry Moreland, MD
Title:Immune Relevance of Prevotella copri, a Gut Microbe, in Patient with Rheumatoid Arthritis
Presenter: Allan C. Steere, MD
Authors:
Allan C. Steere, MD
—
Professor of Medicine, Harvard Medical School
Director of Translational Research in Rheumatology, Massachusetts General Hospital
No relationships with industry relevant to the content of this educational activity have been disclosed.
No relationships with industry relevant to the content of this educational activity have been disclosed.
Larry Moreland, MD
—
Margaret Jane Miller Endowed Professor of Arthritis Research
Chief, Division of Rheumatology and Clinical Immunology
Dr. Moreland receives research funding from NIH, Genentech, Pfizer, Mallinckrodt Pharmaceuticals, Roche, and Bristol Myers Squibb. Dr. Moreland is a consultant with Pfizer (DSMB) and Boehringer Ingelheim (DSMB).
Dr. Moreland receives research funding from NIH, Genentech, Pfizer, Mallinckrodt Pharmaceuticals, Roche, and Bristol Myers Squibb. Dr. Moreland is a consultant with Pfizer (DSMB) and Boehringer Ingelheim (DSMB).
No other members of the planning committee, speakers, presenters,
authors, content reviewers and/or anyone else in a position to
control the content of this education activity have relevant
financial relationships with any companies whose primary business
is producing, marketing, selling, re-selling, or distributing
healthcare products used by or on patients.
The University of Pittsburgh is an affirmative action, equal opportunity institution.